Want to supercharge AI vs. COVID? Get more humans in the learning loop

For AI to make a truly damaging dent in COVID-19’s armor, developers need to better connect big-data analytics with regularly refreshed input from frontline healthcare workers.

Stated another way, AI assigned to the COVID case needs to incorporate human-in-the-loop machine learning, or “HIL ML.”  

An exec with a healthcare AI company spells out the particulars of the opportunity in an opinion piece published online by the Brookings Institution.

A “fundamental disconnect has hindered healthcare for decades—those who deliver the care have the least voice in how care is delivered,” writes Drew Arenth of Seattle-based macro-eyes. “It can be resolved with minimal disruption using HIL ML to engage an educated and impassioned community of health workers.”

Defining HIL ML as the process of receiving data-rich insights from people, analyzing them in real time and sharing recommendations back, Arenth points out that AI in healthcare has been successful in spots but underutilized overall.

“COVID-19 is the greatest global crisis of our time: an immediate health challenge and a challenge of yet unknown duration on the economic and psychological well-being of our society,” he writes. “The lack of data-driven decisionmaking and the absence of adaptive and predictive technology have prolonged and exacerbated the toll of COVID-19. It will be the adoption of these technologies that helps us to rebuild health and society.”

Read the rest:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”